Inari Medical Stock Gets RS Rating Upgrade
Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Continue reading View comments
- Supported exchanges /
- NASDAQ /
- PODD.NASDAQ
Insulet Corporation (PODD NASDAQ) stock market data APIs
$261.26
-4.42(-1.7%)
as of December 26, 2024
Price chart is built with Anychart
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Insulet Corporation Financial Data Overview
| 265.68 | |
| 261.26 | |
| - | |
| 266.42 | |
| 261.26 | |
| 160.19-279.77 | |
| 18 464 M | |
| 44.8433 | |
| 70 145 K | |
| 1 984 M | |
| 0.9 | |
| 1.219 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'PODD',
Type:
'Common Stock',
Name:
'Insulet Corporation',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG000R7XX87',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1145197',
EmployerIdNumber:
'04-3523891',
FiscalYearEnd:
'December',
IPODate:
'2007-05-15',
InternationalDomestic:
'Domestic',
Sector:
'Healthcare',
Industry:
'Medical Devices',
HomeCategory:
'Domestic',
IsDelisted:
false,
}
Insulet Corporation Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 984 M
- EBITDA 411 M
- Earnings Per Share 5.87
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Insulet Corporation Earnings via APIs
- Latest Release 2024-11-07
- EPS/Forecast 0.76
Get Insulet Corporation End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Insulet Corporation latest news via APIs
Novocure Stock Earns 96 RS Rating
On Tuesday, Novocure[ticker symb=NVCR] stock got a positive adjustment to its Relative Strength (RS) Rating, from 73 to 96. The oncology company had some good news Monday announcing success in its pancreatic cancer study. Continue reading View comments
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
